Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, and Cancer Treatment and Pharmacology.
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i> -Rearranged Cancers
A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m<sup>2</sup>for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer